Posted September 17, 2019
Ibrahim YH, Garcia-Garcia C, Serra V, He L, Torres-Lockhart K, Prat A, Anton P, Cozar P, Guzman M, Grueso J, Rodriguez O, Calvo MT, Aura C, Diez O, Rubio IT, Perez J, Rodon J, Cortes J, Ellisen LW, Scaltriti M, Baselga J. PI3K Inhibition impairs BRCA-1/2 expression and sensitizes BRCA-proficient triplenegative breast cancer to PARP Inhibition. Cancer Discov. 2012 Nov;2(11):1036-47.